SteadyMed announced that it recently completed the manufacturing of required batches of its drug candidate Trevyent, designed to treat pulmonary…
Articles by Malika Ammam, PhD
Karos Pharmaceuticals announced that is advancing its small molecule drug candidate, KAR5585, in clinical testing as a treatment for pulmonary arterial hypertension (PAH) and…
A recent study suggests that RNA fragments called microRNAs (miRNAs), long thought of as genetic “junk,” actually control the production of endothelial cells,…
A recent perspective study explores catheter therapies as an alternative treatment for patients with pulmonary arterial hypertension (PAH) who do not…
A recent review study has found that patients with HIV in Africa have a higher than average prevalence of developing pulmonary arterial…
Recently published research reveals that orthopedic (musculoskeletal) surgery in patients with pulmonary hypertension (PH), while challenging, is feasible and offers decent outcomes even in severe…
A recently published paper in Journal of Pathology and Translational Medicine entitled “…
In a recent collaborative research project published in the PLOS one journal entitled “…